Cardiac involvement in patients with limb-girdle muscular dystrophy type 2 and becker muscular dystrophy

Archives of Neurology

Volumn 65, Issue 9, 2008, Pages 1196-1201

  Sveen, Marie Louise ^a,c   Thune, Jens Jakob ^b   Køber, Lars ^b   Vissing, John ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BECKER MUSCULAR DYSTROPHY; CHILD; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART DISEASE; HUMAN; HUMAN TISSUE; LIMB GIRDLE MUSCULAR DYSTROPHY; LIMB GIRDLE MUSCULAR DYSTROPHY TYPE 2; MAJOR CLINICAL STUDY; MALE; MUSCLE BIOPSY; MUSCLE STRENGTH; OUTCOME ASSESSMENT; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCULAR DYSTROPHIES, LIMB-GIRDLE; MUSCULAR DYSTROPHY, DUCHENNE; PROSPECTIVE STUDIES;

EID: 51649084872     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.65.9.1196     Document Type: Article

References (21)

1. Bushby KM. Diagnostic criteria for the limb-girdle muscular dystrophies: report of the ENMC Consortium on Limb-Girdle Dystrophies. Neuromuscul Disord. 1995;5(1):71-74.
2. Nigro G, Comi LI, Politano L, Nigro G. Cardiomyopathies associated with muscular dystrophies. In: Nogueira I, Davis K, eds. Myology. 3rd ed. New York, NY: McGraw-Hill; 2007:1239-1300.
3. Merlini L, Mazzone ES, Solari A, Morandi L. Reliability of hand-held dynamometry in spinal muscular atrophy. Muscle Nerve. 2002;26(1):64-70.
4. Sveen ML, Schwartz M, Vissing J. High prevalence and phenotype-genotype correlations of limb girdle muscular dystrophy type 2I in Denmark. Ann Neurol. 2006;59(5):808-815.
5. Lang RM, Bierig M, Devereux RB, et al; Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18(12):1440-1463.
6. Nielsen OW, Hilden J, Larsen CT, Hansen JF. Cross sectional study estimating prevalence of heart failure and left ventricular systolic dysfunction in community patients at risk. Heart. 2001;86(2):172-178.
7. Nigro G, Comi LI, Politano L, et al. Evaluation of the cardiomyopathy in Becker muscular dystrophy. Muscle Nerve. 1995;18(3):283-291.
8. Bushby K, Muntoni F, Bourke JP. 107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. Neuromuscul Disord. 2003;13(2):166-172.
9. Fougerousse F, Anderson LV, Delezoide AL, Suel L, Durand M, Beckmann JS. Calpain3 expression during human cardiogenesis. Neuromuscul Disord. 2000;10(4-5):251-256.
10. Walter MC, Petersen JA, Stucka R, et al. FKRP (826C>A) frequently causes limb-girdle muscular dystrophy in German patients. J Med Genet. 2004;41(4):e50. doi:10.1136/jmg.2003.013953.
11. Poppe M, Bourke J, Eagle M, et al. Cardiac and respiratory failure in limb-girdle muscular dystrophy 2I. Ann Neurol. 2004;56(5):738-741.
12. Fougerousse F, Durand M, Suel L, et al. Expression of genes (CAPN3, SGCA, SGCB, and TTN) involved in progressive muscular dystrophies during early human development. Genomics. 1998;48(2):145-156.
13. Ettinger AJ, Feng G, Sanes JR. ε-Sarcoglycan, a broadly expressed homologue of the gene mutated in limb-girdle muscular dystrophy 2D. J Biol Chem. 1997;272(51):32534-32538.
14. Duclos F, Straub V, Moore SA, et al. Progressive muscular dystrophy in α-sarcoglycan-deficient mice. J Cell Biol. 1998;142(6):1461-1471.
15. Politano L, Nigro V, Passamano L, et al. Evaluation of cardiac and respiratory involvement in sarcoglycanopathies. Neuromuscul Disord. 2001;11(2):178-185.
16. Fanin M, Melacini P, Boito C, Pegoraro E, Angelini C. LGMD2E patients risk developing dilated cardiomyopathy. Neuromuscul Disord. 2003;13(4):303-309.
17. Ben Hamida M, Ben Hamida C, Zouari M, Belal S, Hentati F. Limb-girdle muscular dystrophy 2C: clinical aspects. Neuromuscul Disord. 1996;6(6):493-494.
18. Dinçer P, Leturcq F, Richard I, et al. A biochemical, genetic, and clinical survey of autosomal recessive limb girdle muscular dystrophies in Turkey. Ann Neurol. 1997;42(2):222-229.
19. Melacini P, Fanin M, Danieli GA, et al. Cardiac involvement in Becker muscular dystrophy. J Am Coll Cardiol. 1993;22(7):1927-1934.
20. Duboc D, Meune C, Pierre B, et al. Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years' follow-up. Am Heart J. 2007;154(3):596-602.
21. SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 1992;327(10):685-691.